M Matthew Loar

Affiliations

  • Chief Financial Officer at Mateon Therapeutics Inc (MATN), 2018-06-22
  • Director at Transcept Pharmaceuticals Inc (TSPT), 2014-10-30
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MATN $0.00 250,000 Officer 300,000 2018-04-12 Filing